Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
AIDS Research and Human Retroviruses|July 6, 2013
Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype CJessica M Mates, Surender B Kumar, Jose Bazan, et al.
Current Oncology (Toronto, Ont.)|August 17, 2018
Real-world patient- and caregiver-reported outcomes in advanced breast cancerV Lambert-Obry, A Gouault-Laliberté, A Castonguay, et al.
Folia Biologica|December 20, 2012
Association between a marker on chromosome 9 and acute coronary syndrome. confirmatory study on Czech populationJ A Hubáček, V Staněk, M Gebauerová, et al.
Molecular Biology Reports|March 27, 2015
Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndromeJ A Hubacek, V Staněk, M Gebauerová, et al.
Scientific Reports|February 12, 2016
Scavenger receptor B1, the HDL receptor, is expressed abundantly in liver sinusoidal endothelial cellsLatha P Ganesan, Jessica M Mates, Alana M Cheplowitz, et al.
Breast (Edinburgh, Scotland)|November 26, 2020
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomitingM Clemons, G Dranitsaris, M Sienkiewicz, et al.
Frontiers in Immunology|February 8, 2017
Mouse Liver Sinusoidal Endothelium Eliminates HIV-Like Particles from Blood at a Rate of 100 Million per Minute by a Second-Order Kinetic ProcessJessica M Mates, Zhili Yao, Alana M Cheplowitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2016
Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density LipoproteinZhili Yao, Jessica M Mates, Alana M Cheplowitz, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 5, 2008
[Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP]M Le Meignen, P Mossler, M Mates, et al.
Investigational New Drugs|October 15, 2018
Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimensJ R Goffin, G Nicholas, M Mates, et al.
Pageof 10